Biotech News Alert: GenSpera's (OTCQB:GNSZ) CEO Shares Insight on Unique Properties and Targeting of Lead Drug G-202, Based on the Thapsigargin Toxin
POINT ROBERTS, Wash. and NEW YORK - August 5, 2014 (Investorideas.com Biotech Newswire) Investorideas.com, a global news source covering leading sectors including biotech, issues an exclusive Q&A interview with Dr. Craig Dionne, PhD, GenSpera's (OTCQB:GNSZ) CEO. Dr. Dionne discusses the company's lead drug G-202 and how they have ... Read more
Biotech News Alert: GenSpera (OTCQB:GNSZ) to Present at Rodman & Renshaw 16th Annual Global Investment Conference
CEO to Present Significance of Announced Clinical Trial Results for Lead Drug G-202 Treating Hepatocellular Carcinoma (HCC) Patients to Wall Street Audience
SAN ANTONIO, Texas, August 14, 2014 – (Investorideas.com Biotech Newswire) GenSpera, Inc. (OTCQB:GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, ... Read more
GenSpera (OTCQB:GNSZ) Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids
SAN ANTONIO - August 28, 2014 (Investorideas.com Biotech Newswire) GenSpera, Inc. (OTCQB:GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the recent publication of the article "Targeting thapsigargin towards tumors" in the journal Steroids.
Biotech News Alert: GenSpera (OTCQB:GNSZ) to Present Lead Drug Candidate Mipsagargin at 2nd Global Life Sciences Conference in Warsaw, Poland
SAN ANTONIO - September 30, 2014 (Investorideas.com Biotech Newswire) GenSpera, Inc. (OTCQB:GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces Craig Dionne, PhD, GenSpera's CEO, will be presenting at the upcoming 2nd ... Read more
Biotech News Alert: GenSpera, Inc. (OTCQB:GNSZ) Featured in TheStockRadio.com Interview
SAN ANTONIO - December 2, 2014 (Investorideas.com Biotech Newswire) GenSpera, Inc. (OTCQB:GNSZ), a leader in developing innovative prodrug therapeutics for the treatment of cancer, releases a recent audio interview with TheStockRadio.com. Craig Dionne, PhD, GenSpera's CEO, discusses the company's background ... Read more
Biotech News Alert: GenSpera (OTCQB:GNSZ) Live and Interactive Virtual Road Show on Dec 16th at 11:30 a.m. ET
December 15, 2014 (Investorideas.com Biotech Newswire) GenSpera, Inc. (OTCQB:GNSZ), a leader in developing innovative prodrug therapeutics for the treatment of cancer, announces its interactive virtual road show for interested investors.